ScholarWorks@Korea University College of Medicine: Park, Sungsoo

Detailed Information

Park, Sungsoo (박성수)

Anam Hospital (Department of Foregut Surgery, Anam Hospital)

Research Area: 위암, 비만대사수술, 위식도역류, Gastric cancer, Bariatirc metabolic surgery, GERD

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

gastric cancer:24||Gastric cancer:21||Gastrectomy:15||Stomach neoplasms:13||Bariatric surgery:10||Laparoscopy:9||gastrectomy:9||laparoscopy:8||Type 2 diabetes:6||bariatric surgery:6||laparoscopic surgery:5||Recurrence:5||Metabolic surgery:5||Sleeve gastrectomy:5||Fundoplication:5||minimally invasive surgery:5||Adjuvant chemotherapy:4||Gastroesophageal reflux:4||Obesity:4||robotic surgery:4||sleeve gastrectomy:4||위암:4||prognosis:4||Early gastric cancer:3||Advanced gastric cancer:3||Polymorphism:3||RouxenY gastric bypass:3||Robotic surgery:3||Ecadherin:3||Subtotal gastrectomy:3||stomach:3||Metaanalysis:3||Prognosis:3||Quality of life:3||stomach neoplasms:3||quality of life:3||Gastroesophageal reflux disease:3||Metabolomics:3||예후 인자:2||Insulin resistance:2||prognostic factor:2||Stomach:2||Proton pump inhibitors:2||amino acid:2||Lymph node metastasis:2||Gastrointestinal stromal tumor:2||metabolomics:2||Billroth:2||Survival:2||Hamartoma:2||morbidity:2||Robotic gastrectomy:2||combined resection:2||surgical outcome:2||immunohistochemistry:2||Laparoscopic:2||Cytokine:2||Laparoscopic sleeve gastrectomy:2||obesity:2||weight loss:2||Mortality:2||Gastric carcinoma:2||림프절 전이:2||laparoscopic gastrectomy:2||서혜부:2||Learning curve:2||예후:2||Prediction:2||120170:2||종양성 석회증:2||Type 2 diabetes mellitus:2||Intraperitoneal chemotherapy:1||Iron:1||Ki67:1||Korea:1||Laparoscopic cancer surgery:1||Laparoscopic fundoplication:1||Laparoscopic total gastrectomy:1||Laparoscopically assisted distal gastrectomy (LADG):1||Laparoscopyassisted distal gastrectomy:1||Lipidomics:1||Locally advanced gastric cancer:1||Lower body mass index:1||Luteolin:1||Lymph nodes:1||Lymphadenectomy:1||Lymphatic metastasis:1||Magnetic resonance imaging:1||Maximum standardized uptake value:1||Medication discontinuation:1||Menetrier's disease:1||Metabolic diseases:1||Metabolic tumor volume:1||Metabolites:1||Micrometastasis:1||Minimal Access Surgery:1||Minimally invasive surgery:1||Minimally invasive treatment:1||Morbidity:1||Multidetector computed tomography:1||Multidetectorrow computed tomography:1||Multiple:1||Muscularis propria:1||N3:1||NCCN:1||Nationwide survey:1||Negative resection margin:1||Nissen fundoplication:1||OCTA (OCT angiography):1||Open total gastrectomy:1||Operation time:1||Operative time:1||Opsonophagocytic activity:1||Osteoporosis:1||Outcomes:1||Oxaliplatin:1||PET/CT:1||PRL3:1||Pancreaticoduodenectomy:1||Partial fundoplication:1||Peritoneal metastasis:1||Phase III:1||Polyvalent pneumococcal conjugate vaccine:1||Positive resection margin:1||Positron Emission Tomography Computed Tomography:1||Postmenopause:1||Postoperative complications:1||Predictor:1||Prognostic facor:1||Prognostic factors:1||Proton pump inhibitor:1||Proximal resection margin:1||Qualityadjusted life years:1||RNA in situ hybridization:1||Radical gastrectomy for gastric cancer:1||Randomized controlled trial:1||Reconstruction method:1||Remission:1||Resection margin:1||Risk:1||Robot surgery:1||Robotic Surgery:1||Robotic cancer surgery:1||RouxenY:1||S1:1||S6 kinase:1||Salvage technique:1||Sarcopenia:1||Scores:1||Selfexpandable metal stent:1||Simulation:1||Single institution:1||Single nucleotide:1||Single port:1||Singlenucleotide polymorphism:1||Singleport surgery:1||Size:1||Skeletal muscle:1||Small submucosal tumor:1||Soft tissue calcification:1||Staple height:1||Stomach Neoplasms:1||Stomach cancer:1||Stomach neoplasm:1||Stomach wall thickness:1||Submucosal Tumor:1||Superobesity:1||Surgery:1||Surgical anastomosis:1||Surgical outcome:1||Surgical resection:1||Surgical treatment:1||Surveillance:1||Survival rate:1||Symptom improvement:1||Systemic review:1||T4:1||T4 gastric cancer:1||T4a:1||T4b:1||TAPP:1||TNEalpha308:1||Total gastrectomy:1||Totally laparoscopic distal gastrectomy:1||Totally laparoscopic distal gastrectomy (TLDG):1||Training:1||Treatment outcome:1||Trend:1||Trocar placement:1||Tumor location:1||Tumor necrosis factoralpha:1||Tumoral calcinosis:1||Type 2 DM:1||Vessel Sealer Extend (R) (VSE):1||Visceral fat:1||Vitamin B12:1||Weight loss:1||acellular dermal matrix:1||adjuvant therapy:1||advanced gastric cancer:1||anastomosis:1||anastomotic leak:1||antiperistaltic:1||aromatic amino acids:1||baseline survey:1||beta cell function:1||bile reflux:1||bipolar vesselsealing device:1||body weight:1||ckit:1||calcium & bone:1||capecitabine:1||cardiopulmonary exercise test:1||cardiovascular risk:1||chemosensitivity test:1||clinical trial:1||cohort study:1||colorectal cancer:1||complication:1||costeffectiveness:1||deconvolution:1||deep learning (DL):1||defect wall suture repair:1||dementia:1||diabetes:1||diabetes & endocrinology:1||diabetes mellitus:1||digital health:1||digital therapeutics:1||direct inguinal hernia:1||distal gastrectomy:1||double cancer:1||eHealth:1||early gastric cancer:1||ectopic liver:1||endoscopic resection:1||energy homeostasis:1||estrogen receptor a:1||estrogen receptor ss:1||extent of gastric resection:1||extragastrointestinal stromal tumor:1||extrahepatic bile duct cancer:1||fatfree mass:1||fibroblast growth factor 1:1||fluorescein:1||function preserving surgery:1||fundoplication:1||gallbladder cancer:1||gastric Cancer:1||gastric bypass:1||gastric neoplasm:1||gastroesophageal reflux:1||gastroesophageal reflux disease:1||gastrointestinal stormal tumor:1||gastrointestinal stromal tumor:1||gastrointestinal stromal tumor (GIST):1||glucose intolerance:1||greater omentum:1||health outcomes:1||hepatocelluar carcinoma:1||highresolution esophageal manometry:1||histology:1||human MutS Homolog 2:1||hypothalamus:1||imageguided surgery:1||immunohistochemisty:1||indocyanine green:1||indole3pyruvic acid:1||insulin secretion:1||insulin sensitivity:1||intersphincteric resection:1||intraperitoneal chemotherapy:1||irinotecan:1||isoperistaltic:1||korea:1||laparoscopic:1||laparoscopic fundoplication:1||laparoscopic surgical tool:1||laser and laser optics:1||learning curve:1||liver intestinecadherin:1||liverintestine cadherin:1||lncATMIN4:2:1||long noncoding RNA:1||longterm prognosis:1||lower esophageal sphincter:1||lymph node:1||lymph node dissection:1||lymph node metastasis:1||lymph node micrometastasis:1||lymphadenectomy:1||lymphatic invasion:1||mHealth:1||malignancy:1||meal pattern:1||medical optics instrumentation:1||mesenteric tumor:1||metaanalysis:1||metabolic:1||metabolic surgery:1||metabolic syndrome:1||metastasis:1||metformin:1||miR495:1||miR551a:1||micronutrients:1||middlethird AGC:1||minimally invasive surgical procedures:1||mismatch repair:1||morbid obesity:1||morbidity and mortality:1||mucin:1||multicenter study:1||multidisciplinary treatment:1||muscularis propria:1||mutation:1||navigation surgery:1||neuroendocrine carcinoma:1||neuromuscular block:1||nodenegative:1||nutritional supplementation:1||oncometabolic surgery:1||operation time:1||optical coherence tomography:1||optical coherence tomography (OCT):1||optical coherent tomography (OCT):1||optical frequency domain imaging:1||outcome studies:1||overall survival:1||p21:1||peritoneal carcinomatosis:1||plateletderived growth factor receptor:1||polysplenia:1||positron emission tomography:1||post recurrence survival:1||postoperative complications:1||potential marker:1||prediction:1||prognostic factors:1||proton pump inhibitors:1||pyloric stenosis:1||quality of Life:1||randomized controlled trial:1||rectal neoplasm:1||recurrence:1||reduced port laparoscopic surgery:1||reducedport robotic distal gastrectomy (RRDG):1||rehabilitation:1||retention index:1||retroperitoneum:1||review:1||robot surgery:1||robotic gastrectomy:1||robotic surgical procedures:1||rouxeny gastric bypass:1||sentinel node:1||situs ambiguus:1||skip metastasis:1||squamous cell carcinoma:1||stageIV:1||standardized uptake value:1||stomach cancer:1||stomach neoplasm:1||subClassification:1||submucosal tumor (SMT):1||surgery:1||surgical anastomosis:1||surgical option for midgastric cancer:1||thyroid disease:1||total laparoscopic:1||transumbilical lymphadenectomy using an articulating BVSD (TULAB):1||treatment:1||tumor heterogeneity:1||type 2 diabetes:1||umbrella review:1||vascular dementia:1||vascular invasion:1||visible light:1||vitamin:1||whole transcriptome sequencing:1||고유근층:1||단일 병원:1||생존율:1||암성통증:1||연부조직 석회화:1||외과적 치료:1||재발:1||제4기:1||조기위암:1||지침:1||120158:1||크기:1||2D laparoscopy:1||3D laparoscopy:1||ABCD score:1||AMPactivated protein kinase:1||Aged:1||Alzheimer's disease:1||Amino acid:1||Amino acids:1||Anastomosis:1||Anemia:1||Antiproliferation:1||Articulating device:1||Asia:1||BMI:1||Bariatric Surgery:1||Billroth II:1||Body mass index:1||Borrmann type 4:1||Braun:1||Brunner's gland:1||CCNE1:1||Castleman's disease:1||Cell cycle arrest:1||Complication:1||Complications:1||Computed tomography:1||Computerassisted image processing Laparoscopy:1||Control:1||Cost of illness:1||Costs:1||Delayed gastric emptying:1||Diabetes:1||Diabetes mellitus:1||Diabetes remission:1||Diseasefree survival:1||Duodenum:1||Duration of neoadjuvant chemotherapy:1||Dyslipidemia:1||Dysphagia:1||Eselectin:1||EMR/ESD:1||Elderly:1||Endometriosis:1||Endoscopy:1||Enzymelinked immunosorbent assay:1||F18 FDG PET/CT:1||F18fluorodeoxyglucose:1||FDG PET/CT:1||GSTT1:1||Gastric bypass:1||Gastric cancer surgery:1||Gastric neoplasms:1||Gastrointestinal Hemorrhage:1||Gastrointestinal stromal tumors:1||Genetic:1||Glutathione Stransferase T1:1||Glycemic index:1||HCC:1||Human MutL Homolog 1:1||Hypertension:1||IL1 beta511:1||IMS score:1||Immunogenicity:1||Impression:1||Inguinal region:1||Insulin secretion:1||Intercellular adhesion molecule1:1||Interleukin1beta:1||Intraabdominal fat:1||Intramuscular fat:1||

STATISTICS: Total View :14,180,415; Today View :9,431

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE